Merck MRK
NYSE MRK
$145.57 +3.17 (+2.23%)
At close: Oct 9, 2026 · 4:00 PM EDT

Merck (MRK) Other Accumulated Expenses (2009 - 2026)

Updated

Merck (MRK) posted Other Accumulated Expenses of $14.73 billion for Q2 2026, up 1.5% from $14.5 billion a year earlier and up 1.2% from the prior quarter.

Analysis

Merck (MRK) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

At the end of FY2025, Merck's Other Accumulated Expenses came in at $14.47 billion, down 7.8% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
  • In prior years, Merck's Other Accumulated Expenses was $15.69 billion in FY2024 (-0.5%), $15.77 billion in FY2023 (+11.3%), $14.16 billion in FY2022 (+2.2%) and $13.86 billion in FY2021 (+13.5%).
  • Quarterly Other Accumulated Expenses has run from a low of $12.77 billion in Q1 2025 to a high of $16.54 billion in Q3 2024 over five years.
  • On a year-over-year basis, Other Accumulated Expenses increased in three of the last eight quarters, with growth averaging 0.7%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2021, with growth of 21.6%; the weakest was Q1 2025, with a decline of 9.4%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $14.55 billion (Q1 2026), $14.47 billion (Q4 2025) and $16.19 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.73 Bn
Mar 31, 2026 14.55 Bn
Dec 31, 2025 14.47 Bn
Sep 30, 2025 16.19 Bn
Jun 30, 2025 14.50 Bn
Mar 31, 2025 12.77 Bn
Dec 31, 2024 15.69 Bn
Sep 30, 2024 16.54 Bn
Jun 30, 2024 14.71 Bn
Mar 31, 2024 14.10 Bn
Dec 31, 2023 15.77 Bn
Sep 30, 2023 14.84 Bn
Jun 30, 2023 13.75 Bn
Mar 31, 2023 13.00 Bn
Dec 31, 2022 14.16 Bn
Sep 30, 2022 14.22 Bn
Jun 30, 2022 13.50 Bn
Mar 31, 2022 14.05 Bn
Dec 31, 2021 13.86 Bn
Sep 30, 2021 14.21 Bn
API Access

Merck Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MRK&period=max&api_key=YOUR_API_KEY